Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CluePoints named as Finalist in 2025 ACDM Awards

    Feb 19, 2025, 08:58 AM by
    CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.
    Full story
  • Sapio Sciences Expands Leadership Team to Drive Growth

    Feb 19, 2025, 08:58 AM by
    Sapio Sciences today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new Scientific Office, Sapio is reinforcing its commitment to scientific and customer-driven innovation.
    Full story
  • AI in Healthcare: How To Assess What Works

    Feb 18, 2025, 08:22 AM by User Not Found
    Bio-IT World| At a panel discussion this week at the ViVE conference in Nashville, Tenn., researchers and physicians discussed the promise and hype of AI. Moderated by Alexander Morgan, partner at Khosla Ventures, the discussion was wide ranging and discussed the AI tools ready for use by physicians; which classes of AI are not yet delivering; and how to assess what’s right for you.
    Full story
  • Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

    Feb 14, 2025, 07:53 AM by
    Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.
    Full story
  • Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

    Feb 14, 2025, 07:53 AM by
    The second annual Bio-IT World Venture, Innovation & Partnering Conference, taking place April 3 in Boston, will bring together 200+ venture capitalists, private equity professionals, bankers, government partners, and entrepreneurs who are advancing the growth of the TechBio, biotech, drug discovery and healthcare sectors.
    Full story
  • Ultima Genomics Sequencing Platform Selected for UK Biobank Study

    Feb 14, 2025, 01:00 AM by User Not Found
    Bio-IT World| Last month, Ultima Genomics announced that their UG 100 sequencing platform was selected by UK Biobank to be used in their human proteomics study, which is anticipated to be the largest and most comprehensive proteomics study to date. The study is intended to quantify more than 5,400 protein markers across 600,000 samples, which will help researchers understand how protein levels fluctuate over time and how these changes correlate with disease progression and aging.
    Full story
  • JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform

    Feb 13, 2025, 08:25 AM by
    JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.
    Full story
  • Epigenetics Alone Can Alter Cancer Susceptibility

    Feb 13, 2025, 01:00 AM by User Not Found
    Bio-IT World| Evidence is emerging that epigenetic differences prior to birth can signal the type of cancer that occurs decades later by dictating which mutated cells turn into a tumor. It is “underappreciated” that most otherwise healthy people are walking around with cancer-causing mutations that their body suppresses unless their built-in defense system mysteriously fails.
    Full story
  • Pillar VC Expands into UK and Launches Encode, an AI for Science Fellowship

    Feb 12, 2025, 08:09 AM by
    Backed by Pillar VC and powered by the Advanced Research + Invention Agency, the Encode Fellowship will place top AI talent in leading UK research labs to accelerate scientific breakthroughs
    Full story
  • GitHub Advanced Security Integrates Endor Labs Software Composition Analysis for End-to-End Application Security

    Feb 12, 2025, 08:09 AM by
    Endor Labs, the leader in open source software security, announced a critical partnership with GitHub, the platform for software developers to create and share code, that makes it easier than ever for application security teams and developers to accurately identify and remediate the most serious security vulnerabilities—all without leaving GitHub.
    Full story
  • Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software

    Feb 12, 2025, 08:09 AM by
    Phreesia is proud to announce that Sally Thayer, Vice President of Product Management, has been named to The Software Report’s list of the Top 50 Women Leaders in Software of 2024.
    Full story
  • Lifebit, Psifas Partner for Israeli Genomic Medicine Initiative

    Feb 10, 2025, 01:00 AM by User Not Found
    Bio-IT World | On the heels of its announced collaboration with 23andMe, Lifebit, has announced a long-term partnership with Psifas, Israeli Genomic Medicine Initiative. This collaboration will empower groundbreaking advancements in personalized medicine by providing a secure and unified platform for clinical-genomic research across Israel’s diverse population.
    Full story
  • Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

    Feb 7, 2025, 08:24 AM by
    A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.
    Full story
  • Inizio accelerates growth with a trio of strategic leadership appointments

    Feb 7, 2025, 08:24 AM by
    Full story
  • Crystal Ball: At JP Morgan, Companies Predict Trump Administration Impacts

    Feb 6, 2025, 01:00 AM by User Not Found
    Bio-IT World| Market questions always arise with the changing of presidential administration in the United States, though this year’s uncertainty seems a bit heightened. Expected outlooks to NIH funding and other regulatory and even Department of Government Efficiencies (DOGE) changes came up in analyst questions after some of the presentations at the J.P. Morgan Healthcare Conference last month.
    Full story
  • Sapio Sciences Selected by LabConnect to Transform Laboratory Operations

    Feb 5, 2025, 07:47 AM by
    Sapio Sciences today announced that LabConnect has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample tracking, and enhance data management.
    Full story
  • 10X Genomics at JPM: New Products, New Sales Team, New Markets

    Feb 5, 2025, 01:00 AM by User Not Found
    Bio-IT World | 10X Genomics launched a spate of new products in 2024 in both their single cell and spatial areas. “Our view is that eventually, every relevant sample will need to be analyzed with single cell and spatial context,” said Serge Saxonov, 10X CEO and co-founder, in his 2025 J.P. Morgan Healthcare Conference presentation.
    Full story
  • Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

    Feb 4, 2025, 09:01 AM by
    Synexa Life Sciences has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.
    Full story
  • Recursion at JPM: Exscientia Merger and the Coming Virtual Cell

    Feb 4, 2025, 01:00 AM by User Not Found
    Bio-IT World | Chris Gibson, CEO of Recursion, gave the company update last month at the 2025 J.P. Morgan Healthcare Conference. Gibson gave updates on several Recursion pipeline programs for indications including precision oncology, rare disease, and other indications. He also gave updates on the merger with Exscientia and the coming virtual cell.
    Full story
  • Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

    Feb 3, 2025, 09:53 AM by
    Sapio Sciences today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By deploying Sapio’s unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows.
    Full story
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy